North America VNA & PACS Market

North America VNA & PACS Market Size (2024 to 2029)

The size of the North America Vendor Neutral Archive (VNA) & PACS Market has been estimated at USD 1.65 billion in 2024 and is projected to reach USD 2.15 billion by 2029, at a CAGR of 5.41% during the forecast period from 2024 to 2029. 

North America Vendor Neutral Archive (VNA) & PACS Market has developed significantly in recent years with the rise of medical tourism, and this has become one of the drivers of market growth.

The prevalence of obesity is also rising in the United States, which is one of the elements increasing market growth. In addition, technological advances in this area are improving the accuracy and safety of equipment and equipment. Therefore, all these factors contribute to market growth. Also, the critical drivers for market development in this region are lower management costs, more diagnostic patients per hour, ease of processing, and the display and transmission of images after imaging.Aesthetic device side effects and inadequate reimbursement are the major restraints to the North America Vendor Neutral Archive & PACS Market growth.

The increase in body contour surgery in North America indicates a high demand for these procedures. According to the American College of Plastic Surgeons, the number of liposuction procedures in 2017 increased by 5% compared to 2016 in the United States. According to the report, a total of 17.5 million surgical and minimally invasive cosmetic surgeries were performed in the United States in 2017, an increase of 2% compared to 2016. Therefore, as the number of operations in the region increases, so does the market for VNA and PACS is expected to increase.

Medical aesthetic equipment includes several devices used to improve the appearance of people's bodies in medical procedures. The ability of medical cosmetic devices to enhance patient satisfaction and the ability to perform non-invasive to minimally invasive cosmetic procedures is expected to drive the growth of the North America VNA and PACS market. With the advent of the Internet, everyone has access to information, and people are starting to learn more about beautiful programs. All of these factors have increased public awareness of these procedures, thereby increasing medical cosmetic sales and significantly expanding the size of the regional VNA and PACS market.The risk of malfunctions associated and upgrade with the latest technology is the major challenge in the North American market.

This research report on the North America Vendor Neutral Archive (VNA) & PACS Market is segmented and sub-segmented into the following categories.

North America VNA & PACS Market By Business Mode

• Enterprise
• Departmental
• Vendors
• Independent Vendors
• Commercial Vendors

North America VNA & PACS Market By Mode of Delivery

• On-Premise VNA
• Hybrid VNA
• Complete Cloud-Hosted VNA

North America VNA & PACS Market By Business Mode

• Enterprise
• Departmental

North America VNA & PACS Market By Components

• Hardware
• Software

North America VNA & PACS Market By Type of Instruments

• X-ray
• Computed Tomography
• Magnetic Resonance Imaging
• Nuclear Imaging
• Ultrasound

North America VNA & PACS Market  By Mode of Delivery

• Mobile Based
• Cloud-Based
• Client-Server Based

North America VNA & PACS Market  By Country

• United States
• Canada
• Rest of North America

Regionally, the United States leads the market in this region with a share of almost 80%. The North American market is very modern and is focused on innovating cost-effective techniques. Companies are committed to research, sourcing, and quality, factors that are central to the success of the industry.

KEY MARKET PLAYERS

Companies playing a dominant role in the North America Vendor Neutral Archive (VNA) & PACS Market profiled in this report are Acuo Technologies (U.S.), which leads the global VNA market, followed by Agfa HealthCare (Belgium), Carestream Health (U.S.), Dell, Inc. (U.S.), BridgeHead Software (U.K.), Fujifilm Corporation (Japan), Merge Health (U.S.), GE Healthcare (U.K.), Philips Healthcare (The Netherlands), Siemens Healthcare (Germany), McKesson Corporation (U.S.), and TeraMedica (U.S.).